MedTrace Logo

Valor II: The Valiant Thoracic Stent Graft System Clinical Study

NCT00413231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2021-11-03

Study results available
· View outcomes & findings →

Summary

This study was designed to study safety and effectiveness of the Valiant Thoracic Stent Graft to treat thoracic aortic aneurysms.

Conditions

  • Thoracic Aortic Aneurysm

Interventions

DEVICE

Valiant Thoracic Stent Graft System

Surgical procedure in which a device is implanted inside the aorta, isolating the diseased area (aneurysm).

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Ronald Fairman, MD · University of Pennsylvania

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2010-08-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00413231 on ClinicalTrials.gov